125 related articles for article (PubMed ID: 20638609)
1. Evaluation of Vitek2 and BD Phoenix in antimicrobial susceptibility testing of Acinetobacter baumannii and Pseudomonas aeruginosa.
Jekarl DW; Han SB; Kim YJ; Shin SH; Park KG; Park JJ; Han K; Park YJ
Diagn Microbiol Infect Dis; 2010 Aug; 67(4):384-6. PubMed ID: 20638609
[TBL] [Abstract][Full Text] [Related]
2. [Shall we report the carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii strains detected by BD Phoenix system?].
Oğünç D; Ongüt G; Ozen NS; Baysan BO; Günseren F; Dağlar D; Demirbakan H; Gültekin M
Mikrobiyol Bul; 2010 Apr; 44(2):197-202. PubMed ID: 20549953
[TBL] [Abstract][Full Text] [Related]
3. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic comparisons of antimicrobials against nosocomial isolates of escherichia coli, klebsiella pneumoniae, acinetobacter baumannii and pseudomonas aeruginosa from the MYSTIC surveillance program: the OPTAMA Program, South America 2002.
Kiffer CR; Mendes C; Kuti JL; Nicolau DP
Diagn Microbiol Infect Dis; 2004 Jun; 49(2):109-16. PubMed ID: 15183860
[TBL] [Abstract][Full Text] [Related]
5. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
Burgess DS; Frei CR
J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
7. [E-test to study small inhibitor concentrations, bacterial diversity and to identify presumptively beta-lactamases in strains of Pseudomonas aeruginosa and Acinetobacter baumannii associated with +nosocomial infections].
Triantafilo V; Fica A; Silva M; Thompson L
Rev Med Chil; 1997 Feb; 125(2):149-60. PubMed ID: 9430934
[TBL] [Abstract][Full Text] [Related]
8. Activity of doripenem with and without levofloxacin, amikacin, and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.
Pankuch GA; Seifert H; Appelbaum PC
Diagn Microbiol Infect Dis; 2010 Jun; 67(2):191-7. PubMed ID: 20338710
[TBL] [Abstract][Full Text] [Related]
9. Detecting imipenem resistance in Acinetobacter baumannii by automated systems (BD Phoenix, Microscan WalkAway, Vitek 2); high error rates with Microscan WalkAway.
Kulah C; Aktas E; Comert F; Ozlu N; Akyar I; Ankarali H
BMC Infect Dis; 2009 Mar; 9():30. PubMed ID: 19291298
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and antibiotic susceptibility of Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae in Estonian intensive care units in comparison with European data.
Lõivukene K; Sepp E; Adamson V; Mitt P; Kallandi U; Otter K; Naaber P
Scand J Infect Dis; 2006; 38(11-12):1001-8. PubMed ID: 17148068
[TBL] [Abstract][Full Text] [Related]
11. In-vitro bactericidal activity of colistin against biofilm-associated Pseudomonas aeruginosa and Acinetobacter baumannii.
Cai Y; Wang R; Liang BB; An MM
J Hosp Infect; 2009 Aug; 72(4):368-70. PubMed ID: 19443079
[No Abstract] [Full Text] [Related]
12. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
Zarakolu P; Hasçelik G; Unal S
Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
[TBL] [Abstract][Full Text] [Related]
13. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy.
Zavascki AP; Carvalhaes CG; Picão RC; Gales AC
Expert Rev Anti Infect Ther; 2010 Jan; 8(1):71-93. PubMed ID: 20014903
[TBL] [Abstract][Full Text] [Related]
14. Impact of ertapenem use on Pseudomonas aeruginosa and Acinetobacter baumannii imipenem susceptibility rates: collateral damage or positive effect on hospital ecology?
Sousa D; Castelo-Corral L; Gutiérrez-Urbón JM; Molina F; López-Calviño B; Bou G; Llinares P
J Antimicrob Chemother; 2013 Aug; 68(8):1917-25. PubMed ID: 23557925
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City.
Landman D; Kelly P; Bäcker M; Babu E; Shah N; Bratu S; Quale J
J Antimicrob Chemother; 2011 Feb; 66(2):332-4. PubMed ID: 21131322
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of metallo-beta-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii isolated from burn wounds and in vitro activities of antibiotic combinations against these isolates.
Altoparlak U; Aktas F; Celebi D; Ozkurt Z; Akcay MN
Burns; 2005 Sep; 31(6):707-10. PubMed ID: 16129224
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic target attainment of six beta-lactams and two fluoroquinolones against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and Klebsiella species collected from United States intensive care units in 2004.
DeRyke CA; Kuti JL; Nicolau DP
Pharmacotherapy; 2007 Mar; 27(3):333-42. PubMed ID: 17316145
[TBL] [Abstract][Full Text] [Related]
18. [The drug-resistant mechanism of clinical non-fermenting bacilli producing IMP-1 metalloenzyme].
Cheng X; Jia W; Du B; Zeng W; Kang M; Zhang Z; Xie Y; Yang W; Fan H; Tao C; Zhang L
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Aug; 24(4):876-9. PubMed ID: 17899764
[TBL] [Abstract][Full Text] [Related]
19. Performance of Vitek 2 for Antimicrobial Susceptibility Testing of Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia with Vitek 2 (2009 FDA) and CLSI M100S 26th Edition Breakpoints.
Bobenchik AM; Deak E; Hindler JA; Charlton CL; Humphries RM
J Clin Microbiol; 2017 Feb; 55(2):450-456. PubMed ID: 27881616
[TBL] [Abstract][Full Text] [Related]
20. Investigation of metallo-beta-lactamase producing strains of Pseudomonas aeruginosa and Acinetobacter baumannii by E-test, disk synergy and PCR.
Aktaş Z; Kayacan CB
Scand J Infect Dis; 2008; 40(4):320-5. PubMed ID: 17934980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]